4th Quarter - Amendment
LUNGREN LOPINA LLC for AMPAC FINE CHEMICALS
Firm
Client
Income
$40,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 14, 2020 | $40,000 | Replaced |
| 4th Quarter - Amendment (this page) | Feb 25, 2020 | $40,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Fair treatment for US pharmaceutical ingredients
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN LOPINA | — |
| DANIEL LUNGREN | Member of Congress |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SK HOLDINGS | South Korea | South Korea | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.